These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33604811)

  • 21. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
    Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
    Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High expression of the stemness-associated molecule Nanog in esophageal squamous cell carcinoma tissues promotes tumor invasion and metastasis by activating the TGF-β signaling pathway].
    Sun C; Zheng S; Li M; Yang M; Qin M; Xu Y; Liang W; Hu J; Wang L; Li F; Zhou H; Yang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 44(6):1209-1216. PubMed ID: 38977352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
    Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
    Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial‑mesenchymal transition.
    Xu G; Ou L; Liu Y; Wang X; Liu K; Li J; Li J; Wang S; Huang D; Zheng K; Wang S
    Oncol Rep; 2020 Jul; 44(1):29-42. PubMed ID: 32627007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β-catenin signaling pathway and EMT in esophageal squamous cell carcinoma.
    Meng J; Zhang C; Zhao T; Shi G; Zhao J; Lin Z
    Thorac Cancer; 2021 Mar; 12(6):932-940. PubMed ID: 33538099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
    Zhu X; Han S; Wu S; Bai Y; Zhang N; Wei L
    Exp Cell Res; 2019 Feb; 375(2):41-50. PubMed ID: 30611739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE-30.
    Mahmoudian RA; Bahadori B; Rad A; Abbaszadegan MR; Forghanifard MM
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00746. PubMed ID: 31090196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
    J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.
    Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F
    Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
    Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
    Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
    Li Y; Ma J; Guo Q; Duan F; Tang F; Zheng P; Zhao Z; Lu G
    Dis Esophagus; 2009; 22(8):664-7. PubMed ID: 19191857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.